Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Haemonetics (HAE) Return on Equity (2016 - 2025)

Haemonetics has reported Return on Equity over the past 16 years, most recently at 0.2% for Q4 2025.

  • Quarterly results put Return on Equity at 0.2% for Q4 2025, up 5.0% from a year ago — trailing twelve months through Dec 2025 was 0.2% (up 5.0% YoY), and the annual figure for FY2025 was 0.19%, up 6.0%.
  • Return on Equity for Q4 2025 was 0.2% at Haemonetics, up from 0.19% in the prior quarter.
  • Over the last five years, Return on Equity for HAE hit a ceiling of 0.2% in Q4 2025 and a floor of 0.03% in Q1 2022.
  • Median Return on Equity over the past 5 years was 0.13% (2023), compared with a mean of 0.13%.
  • Biggest five-year swings in Return on Equity: decreased -12bps in 2021 and later increased 10bps in 2022.
  • Haemonetics' Return on Equity stood at 0.05% in 2021, then skyrocketed by 181bps to 0.13% in 2022, then rose by 8bps to 0.14% in 2023, then grew by 6bps to 0.15% in 2024, then surged by 37bps to 0.2% in 2025.
  • The last three reported values for Return on Equity were 0.2% (Q4 2025), 0.19% (Q3 2025), and 0.19% (Q2 2025) per Business Quant data.